189 related articles for article (PubMed ID: 17895822)
1. Efficacy of corticosteroids and external beam radiation in the management of moderate to severe thyroid eye disease.
Zoumalan CI; Cockerham KP; Turbin RE; Volpe NJ; Kazim M; Douglas RS; Feldon SE
J Neuroophthalmol; 2007 Sep; 27(3):205-14. PubMed ID: 17895822
[TBL] [Abstract][Full Text] [Related]
2. Reduced risk of compressive optic neuropathy using orbital radiotherapy in patients with active thyroid eye disease.
Shams PN; Ma R; Pickles T; Rootman J; Dolman PJ
Am J Ophthalmol; 2014 Jun; 157(6):1299-305. PubMed ID: 24582992
[TBL] [Abstract][Full Text] [Related]
3. The use of orbital radiotherapy for Graves' ophthalmopathy: quantitative review of the evidence.
Wei RL; Cheng JW; Cai JP
Ophthalmologica; 2008; 222(1):27-31. PubMed ID: 18097177
[TBL] [Abstract][Full Text] [Related]
4. Low dose orbital radiotherapy for thyroid eye disease.
Li Yim JF; Sandinha T; Kerr JM; Ritchie D; Kemp EG
Orbit; 2011 Dec; 30(6):269-74. PubMed ID: 22132844
[TBL] [Abstract][Full Text] [Related]
5. The use of corticosteroids versus other treatments for Graves' ophthalmopathy: a quantitative evaluation.
Abalkhail S; Doi SA; Al-Shoumer KA
Med Sci Monit; 2003 Nov; 9(11):CR477-83. PubMed ID: 14586273
[TBL] [Abstract][Full Text] [Related]
6. Orbital Radiation for Thyroid Eye Disease: A Report by the American Academy of Ophthalmology.
Sobel RK; Aakalu VK; Vagefi MR; Foster JA; Tao JP; Freitag SK; Wladis EJ; McCulley TJ; Yen MT
Ophthalmology; 2022 Apr; 129(4):450-455. PubMed ID: 34895729
[TBL] [Abstract][Full Text] [Related]
7. Orbital radiation for graves ophthalmopathy: a report by the American Academy of Ophthalmology.
Bradley EA; Gower EW; Bradley DJ; Meyer DR; Cahill KV; Custer PL; Holck DE; Woog JJ
Ophthalmology; 2008 Feb; 115(2):398-409. PubMed ID: 18082885
[TBL] [Abstract][Full Text] [Related]
8. [Radiation therapy for Graves' ophthalmopathy].
Misaki T
Nihon Rinsho; 2006 Dec; 64(12):2287-90. PubMed ID: 17154093
[TBL] [Abstract][Full Text] [Related]
9. Radiation therapy for orbital tumors: concepts, current use, and ophthalmic radiation side effects.
Finger PT
Surv Ophthalmol; 2009; 54(5):545-68. PubMed ID: 19682622
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy for Active Thyroid Eye Disease.
Godfrey KJ; Kazim M
Ophthalmic Plast Reconstr Surg; 2018; 34(4S Suppl 1):S98-S104. PubMed ID: 29771752
[TBL] [Abstract][Full Text] [Related]
11. Orbital radiation therapy for Graves' ophthalmopathy: measuring clinical efficacy and impact.
Hahn E; Laperriere N; Millar BA; Oestreicher J; McGowan H; Krema H; Gill H; DeAngelis D; Hurwitz J; Tucker N; Simpson R; Chung C
Pract Radiat Oncol; 2014; 4(4):233-9. PubMed ID: 25012831
[TBL] [Abstract][Full Text] [Related]
12. [Radiation therapy for thyroid-associated ophthalmopathy].
Luo QL; He WM; Tang L; Chen LJ
Zhonghua Yan Ke Za Zhi; 2006 Mar; 42(3):218-21. PubMed ID: 16643752
[TBL] [Abstract][Full Text] [Related]
13. What to do for moderate-to-severe and active Graves' orbitopathy if glucocorticoids fail?
Bartalena L
Clin Endocrinol (Oxf); 2010 Aug; 73(2):149-52. PubMed ID: 20148907
[TBL] [Abstract][Full Text] [Related]
14. The role of intravenous methylprednisolone immunosuppression in the management of active thyroid eye disease.
Tambe K; Bhargava J; Tripathi A; Gregory M; Burns J; Sampath R
Orbit; 2010 Oct; 29(5):227-31. PubMed ID: 20812826
[TBL] [Abstract][Full Text] [Related]
15. Recent developments in the medical treatment of thyroid eye disease.
Krassas GE; Boboridis K
Orbit; 2006 Jun; 25(2):117-22. PubMed ID: 16754220
[TBL] [Abstract][Full Text] [Related]
16. Orbital Radiotherapy Combined With Corticosteroid Treatment for Thyroid Eye Disease-Compressive Optic Neuropathy.
Gold KG; Scofield S; Isaacson SR; Stewart MW; Kazim M
Ophthalmic Plast Reconstr Surg; 2018; 34(2):172-177. PubMed ID: 29517594
[TBL] [Abstract][Full Text] [Related]
17. Treatment of severe thyroid eye disease: a survey of the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS).
Perumal B; Meyer DR
Ophthalmic Plast Reconstr Surg; 2015; 31(2):127-31. PubMed ID: 24988501
[TBL] [Abstract][Full Text] [Related]
18. Thyroid eye disease: therapy in the active phase.
Bhatti MT; Dutton JJ
J Neuroophthalmol; 2014 Jun; 34(2):186-97. PubMed ID: 24821102
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological treatments for thyroid eye disease.
Modjtahedi SP; Modjtahedi BS; Mansury AM; Selva D; Douglas RS; Goldberg RA; Leibovitch I
Drugs; 2006; 66(13):1685-700. PubMed ID: 16978034
[TBL] [Abstract][Full Text] [Related]
20. Rituximab treatment in a patient with severe thyroid-associated ophthalmopathy: effects on orbital lymphocytic infiltrates.
Salvi M; Vannucchi G; Campi I; Currò N; Simonetta S; Covelli D; Pignataro L; Guastella C; Rossi S; Bonara P; Dazzi D; Ratiglia R; Beck-Peccoz P
Clin Immunol; 2009 May; 131(2):360-5. PubMed ID: 19195932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
